None
Quote | Nexien BioPharma Inc (OTCMKTS:NXEN)
Last: | $0.0163 |
---|---|
Change Percent: | 19.9% |
Open: | $0.0163 |
Close: | $0.0163 |
High: | $0.0163 |
Low: | $0.0163 |
Volume: | 6,032 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Nexien BioPharma Inc (OTCMKTS:NXEN)
Owens Corning Inc New (OC) is expected to report $2.82 for Q4 2023 Getty Realty Corporation (GTY) is expected to report $0.56 for Q4 2023 Bion Environmental Technologies Inc. (BNET) is expected to report for Q2 2024 Nexien BioPharma Inc (NXEN) is expected to report for Q2 2024 Ayt...
The RMR Group Inc. (RMR) is expected to report $0.46 for Q4 2023 Indra Sistemas ADR (ISMAY) is expected to report for Q3 2023 Ceapro Inc. (CRPOF) is expected to report for Q2 2024 Tuya Inc. American Depositary Shares each representing one Class A (TUYA) is expected to report $-0.02 fo...
Message Board Posts | Nexien BioPharma Inc (OTCMKTS:NXEN)
Subject | By | Source | When |
---|---|---|---|
Is Greenburg brain dead? He runs a public | surfgreen | investorshub | 02/02/2023 9:05:21 PM |
Diluting POS turd with no business | surfgreen | investorshub | 01/10/2023 7:54:53 PM |
Sell the shell and end this turd | surfgreen | investorshub | 11/08/2022 7:14:27 PM |
I only saw that shares were awarded to | surfgreen | investorshub | 10/27/2022 4:30:16 PM |
Insiders all buying now | P pete | investorshub | 10/19/2022 5:50:03 PM |
News, Short Squeeze, Breakout and More Instantly...
Owens Corning Inc New (OC) is expected to report $2.82 for Q4 2023 Getty Realty Corporation (GTY) is expected to report $0.56 for Q4 2023 Bion Environmental Technologies Inc. (BNET) is expected to report for Q2 2024 Nexien BioPharma Inc (NXEN) is expected to report for Q2 2024 Ayt...
The RMR Group Inc. (RMR) is expected to report $0.46 for Q4 2023 Indra Sistemas ADR (ISMAY) is expected to report for Q3 2023 Ceapro Inc. (CRPOF) is expected to report for Q2 2024 Tuya Inc. American Depositary Shares each representing one Class A (TUYA) is expected to report $-0.02 fo...
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...